COMMUNIQUÉS West-GlobeNewswire

Angelini Ventures Invests in Hypervision Surgical’s £17 Million Series A to Advance Real-time Hyperspectral Imaging and Improve Clinical Outcomes in Surgery
29/04/2026
Funding will support commercial deployment, clinical adoption and further development and enhancement of the Hyperspectral Intelligence® platform for AI-assisted surgery Angelini Ventures Managing Director Tanja Dowe [...]
AB Science announces the successful completion of a EUR 3.2 million private placement
29/04/2026
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 3.2 MILLION PRIVATE PLACEMENT Paris, April 29, 2026, 8am AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) announces [...]
Enlitic Announces Full Integration with Sectra, Expanding Access for Sectra Customers
29/04/2026
LOVELAND, Colo., April 29, 2026 (GLOBE NEWSWIRE) -- Enlitic today announced the completion of its integration with Sectra, enabling Enlitic to support Sectra customers directly with its Ensight platform. The integration [...]
Phonak Virto ™ R Infinio Earns 2026 Red Dot Award for Product Design
29/04/2026
Recognition highlights precision-crafted customization and next-generation performance in a compact, in-the-ear hearing solution STÄFA, Switzerland, April 29, 2026 (GLOBE NEWSWIRE) -- Phonak, a global leader in [...]
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
29/04/2026
BEIJING, April 28, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER
29/04/2026
Greenville, South Carolina, April 28, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) reports that Felix Mirando has resigned as a member of the Company’s Board of Directors for [...]
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
29/04/2026
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial [...]
Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
29/04/2026
MENLO PARK, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (Nasdaq: ORKA), a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and [...]
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026
28/04/2026
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the [...]
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
28/04/2026
Urges Stockholders to Vote “FOR” Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today Strongly Opposes the Election of Each of DOMA’s Underqualified Nominees BRISBANE, Calif., April 28, 2026 (GLOBE NEWSWIRE [...]
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2026 le 12 Mai 2026
28/04/2026
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2026 le 12 Mai 2026 Mont-Saint-Guibert, Belgique – 28 avril 2026, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « [...]
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026
SAN DIEGO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, [...]
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
28/04/2026
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 Mont-Saint-Guibert, Belgium – April 28, 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that [...]
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
28/04/2026
If approved, ReNu® will revolutionize treatment options for millions of patients with knee OA pain CANTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative [...]
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026
SOUTH SAN FRANCISCO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
28/04/2026
DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for [...]
ASAP Dental Care Sets New Benchmark in Clinical Excellence with Over 229,000 Successful Procedures Performed
28/04/2026
North Florida's Leading Dental Provider Offers an Increased Number of Procedures Across All Locations Jacksonville, FL, April 28, 2026 (GLOBE NEWSWIRE) -- ASAP Dental Care, a cornerstone of the Jacksonville healthcare [...]
Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call
28/04/2026
DALLAS, April 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
28/04/2026
RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and [...]

Pages